Status:
UNKNOWN
A Clinical Trial to Study the Safety and Efficacy of Bone Marrow Derived Autologous Cell for the Treatment of Stroke.
Lead Sponsor:
Chaitanya Hospital, Pune
Conditions:
Stroke,
Eligibility:
All Genders
18-70 years
Phase:
PHASE1
PHASE2
Brief Summary
This study is single, centre trial to study the safety and efficacy of Bone marrow derived autologous MNCS(100 million per dose)trial to be conducted for 36 months in stroke patients , the primary out...
Detailed Description
This study is single centre trial to study the safety and efficacy of Bone marrow derived autologous MNCS(100 million per dose)trial to be conducted for 36 months in stroke patients , the primary outc...
Eligibility Criteria
Inclusion
- Patient should suffer from stroke due to cerebral infarct or Haemorrhage or accelerated hypertension.
- willingness to undergo bone marrow derived autologous cell therapy.
- patient those provide fully Informed consent form for the study.
- Ability and willingness to regular visit to hospital and follow up during the protocol Procedure.
Exclusion
- Patients with pre - existing or Current systemic disease such as lung , liver ( exception; History of uncomplicated Hepatitis A),gastrointestinal, Cardiac , Immunodeficiency,(including HIV) Or laboratory Investigation that could cause a neurological defect.History of Life threating Allergic or immune- mediated reaction.
- Alcohol and drug abuse / dependence.
- Severe skin infection.
- Haemodynamically unstable.
- subject with primary and secondary diabetes , Insulin depenence,
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2016
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01832428
Start Date
September 1 2014
End Date
November 1 2016
Last Update
September 17 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chaitanya Hospital
Pune, Maharashtra, India, 411009